Ads
related to: eli lilly- Press Releases
Find Press Releases
and News for Lilly.
- Lilly Recognitions
Leaders in D&I, R&D, and
Social Impact & Employee Benefits
- About Lilly
Find How Lilly's Purpose Has Never
Been More Important.
- Our Impact
Learn About How We Responsibly
Grow Our Business.
- Press Releases
Search results
...Therapeutics' Obesity Candidate Is ' Very Competitive' To Eli Lilly's Orforglipron, Analyst Says...
Benzinga· 4 hours agoStructure Therapeutics reports positive 12-week Phase 2a obesity study results for GSBR-1290,...
Is Eli Lilly Stock A Buy On A Recent Crohn's Disease-Related Rally?
Investor's Business Daily· 4 days agoEli Lilly stock rocketed and broke out earlier this month after unveiling promising results for its...
Watch Out Wegovy: Here Comes Another Promising Anti-Obesity Candidate | The Motley Fool
The Motley Fool· 10 hours agoInvestors interested in the pharmaceutical industry are currently excited about the anti-obesity...
Eli Lilly adds ALS drug prospect with QurAlis deal
BioPharma Dive via Yahoo Finance· 18 hours agoThe alliance hands Lilly an RNA-based therapy in preclinical testing for ALS and frontotemporal dementia, and includes a research collaboration to...
This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors | The Motley Fool
The Motley Fool· 2 days agoEli Lilly (LLY 0.65%) and Novo Nordisk (NVO 1.87%) are the two most valuable healthcare companies in...
Lilly gilds neuro pipeline, paying QurAlis $45M for preclinical ALS, dementia prospect
FierceBiotech· 14 hours agoEli Lilly is splicing another asset onto its neurodegenerative disease pipeline, paying QurAlis $45 million for rights to a preclinical treatment for amyotrophic ...
These Are The 5 Best Stocks To Buy And Watch Now
Investor's Business Daily· 21 hours agoBuying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a...
Is Eli Lilly And Co (NYSE:LLY) the Best Weight Loss Stock to Buy in 2024?
Insider Monkey via Yahoo Finance· 3 days agoWe recently published a list of Jim Cramer’s Top 10 Stock Picks for June. Since Eli Lilly And Co...
Eli Lilly Plans $5.3B Expansion of Pharmaceutical Manufacturing Facility in Lebanon, Indiana
REBusinessOnline.com· 7 days agoLEBANON, IND. — Eli Lilly and Co. (NYSE: LLY) has released plans for a $5.3 billion expansion of its...
Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030,...
Business Insider· 2 days agoThe anti-obesity drug market will be worth $130 billion by 2030, Goldman Sachs analysts said in a...
Ad
related to: eli lilly